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ABSTRACT
In this multicenter study, we aimed to evaluate the performance of MALDI Biotyper and VITEK MS, for
identification of Prevotella species. Three hundred and fourteen clinical isolates, collected in eight
European countries between January 2014 and April 2016, were identified at the collecting sites by
MALDI Biotyper (versions 3.0 and 3.1) and then reidentified by VITEK MS (version 3.0) in the central
laboratory. 16S rRNA gene sequencing was used as a standard method. According to sequence analysis,
the 314 Prevotella strains belonged to 19 species. MALDI Biotyper correctly identified 281 (89.5%)
isolates to the species level and 33 (10.5%) only at the genus level. VITEK MS correctly identified 253
(80.6%) isolates at the species level and 276 (87.9%) isolates at the genus level. Thirty-three isolates
belonging to P. bergensis, P. conceptionensis, P. corporis, P. histicola, and P. nanciensis, unavailable in the
VITEK MS 3.0 database, were resulted in genus level or no identification. Six Prevotella strains, belonged
to P. veroralis, P. timonensis, and P. conceptionensis not represented in the MALDI Biotyper system
database, were misidentified at the genus level. In conclusion, both VITEK MS and MALDI Biotyper
provided reliable and rapid identification. However, the permanent extension of the databases is needed.
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INTRODUCTION
Prevotella species, obligate anaerobic Gram-negative bacilli, are important members of oral,
upper respiratory, intestinal, and female genital tract microbiota. However, these organisms
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can also cause opportunistic infections, which may involve
any type of oral infection, various types of abscesses, soft
tissue, and sterile site infections in the human body. Suscep-
tibility profiles may vary at the species level; consequently, a
rapid and an accurate identification of Prevotella isolates
plays a critical role in successful treatment [1, 2].
The Prevotella genus has undergone recent taxonomic
changes and the number of validated species has increased to
50 (http://www.bacterio.net/prevotella.html). The identification
of Prevotella isolates classically relies on laborious and time-
consuming phenotypic assays [3]. Nucleic acid sequencing
methods have been developed for more rapid and reliable
identification. However, DNA-based methods for routine iden-
tification of clinical isolates are too expensive, technically
complex, labor-intensive, and need expert interpretation of the
sequences [4]. Due to the various shortcomings of these
methods, there is an increasing interest in more accurate
identification of anaerobic bacteria including Prevotella spp.
in routine microbiological laboratories.
Previous studies have confirmed that matrix-assisted laser
desorption ionization–time-of-flight mass spectrometry
(MALDI-TOF MS) is an accurate, rapid, and satisfactory
method for routine identification of anaerobes in diagnostic
laboratories [5–7]. At present, two MALDI-TOF MS systems
are commercially available for routine use: theMALDI Biotyper
(Bruker Daltonics Inc., Germany) and VITEK MS (bioMérieux
Inc., France). Methodology of the two systems is similar, but
differences are present in composition of databases and appli-
cation of software packages for data analyses [8]. Earlier studies
evaluating MALDI-TOF MS identification of Prevotella spp.
mostly used the MALDI Biotyper system [9, 10].
In a multicenter study organized by ESCMID Study Group
for Anaerobic Infections (ESGAI), we assessed the performance
of the VITEK MS system for the identification of Prevotella
isolates (n= 508) collected in 13 countries for a European
antibiotic resistance surveillance. We found that VITEK MS
offers a reliable and rapid identification of the most frequently
isolated Prevotella species [11]. About two third of the isolates
were also identified by MALDI Biotyper system in eight
participating countries, which made possible to compare the
performance of the two MALDI-TOF MS systems. Compara-
tive studies in the field of clinically relevant anaerobic isolates
on the applicability of different MS systems are limited. In this
study, we describe the identification ability of both MALDI
Biotyper and VITEK MS systems for clinically relevant Pre-
votella species using the 16S rRNA gene sequencing as a
reference method.
MATERIALS AND METHODS
Bacterial isolates
A total of 314 non-duplicate clinically relevant Prevotella
isolates were involved in this study. They were a subset of 508
Prevotella strains collected for European antibiotic resistance
surveillance with the aim to determine the differences in
antibiotic resistance among various species [2]. The 314
Prevotella strains, involved in this study, were collected
between January 2014 and April 2016 in eight European
countries [Belgium (n= 45), Croatia (n= 33), Denmark
(n= 29), France (n= 45), Great Britain (n= 41), Hungary
(n= 47), Netherlands (n= 45), and Slovenia (n= 29)], where
mass spectrometry-based identification was already used in
the routine practice. All centers involved used the MALDI
Biotyper system for identification; however, the software and
databases were slightly different in the different collecting
sites (Table I). The request was to submit all clinical isolates
belonging to genus Prevotella identified by the Bruker Bio-
typer system. Prevotella isolates were sent to Turkey, in
anaerobic transport medium (Anaerobe systems, Morgan Hill,
USA). Upon arrival, the isolates were immediately grown on
Brucella agar (Difco, USA) supplemented with 5% sheep
blood, hemin, and vitamin K1 at 36 °C for 48 h in an anaerobic
chamber (Bactron-I, SHELLAB, USA). Cultures were assessed
in terms of purity. Pure and viable strains were stored at
−80 °C in 10% skimmed milk until further investigations.
To compare the performance of the two MALDI-TOF MS
systems for the identification of Prevotella strains, the isolates
were reidentified using the VITEK MS (database version 3.0)
in the central laboratory in Turkey. Only isolates that gave
species-level identification by the sequencing data were
further compared for the MS-based identification.
Identification by MALDI Biotyper MS
The isolates were identified according to the manufacturer’s
guidelines. Briefly, a colony was smeared onto a spot on the
MALDI plate. The spots were covered with 1 μl of matrix
solution (Bruker Daltonik α-cyano-4-hydroxy-cinnamic acid
in 50% acetonitrile and 2.5% trifluoroacetic acid) and allowed
to air dry. The plate is placed in the ionization chamber of the
Biotyper MS machine. The generated mass spectra were
compared against a database of mass spectra by the software,
resulting in identification of the organism.
All collecting sites used the same criteria for the identifi-
cation during the collection of the strains. Species-level
identification by the MALDI Biotyper was accepted if the
log score was ≥2.000 and genus-level identification if the log
score was between >1.700 and <2.000. Only isolates with
correct genus-level identification were accepted for the study
and were sent to the central laboratory.
Identification by VITEK MS
In case of VITEK MS, according to the manufacturer’s
guidelines, a single colony was applied onto a spot of target
slide as a thin film and allowed to air dry. The spots were
covered with 1 μl of matrix solution (VITEK MS α-cyano-4-
hydroxycinnamic acid) and allowed to dry at room tempera-
ture. Then, the prepared target slide was inserted into the
VITEK MS machine (bioMérieux). Microbial identification
was performed by generating spectra from the bacterial
extracts and comparing them with the reference spectra
using the VITEK MS version 3.0 database.
2 Acta Microbiologica et Immunologica Hungarica (2019), 1–8
Brought to you by University of Szeged | Unauthenticated | Downloaded 04/20/20 11:29 AM UTC
Species-level identification was considered accurate, if
confidence level was ≥99.9% and for a confidence level
ranging between 60% and 99.9% with a single species choice.
Low-level confidence score (<50%) is found in a low dis-
crimination identification consisting of a list of two to four
choices for an identification match. These isolates were
identified only genus level. The bacterium was considered
non-identified, if confidence level value was <60% and no
match for the composite spectra. These criteria were used for
the identification of the isolates in the central laboratory.
Analysis of the MALDI-TOF MS data
MALDI-TOF MS identification data by the two systems
obtained in the collecting laboratories and in the central
laboratory were compared with the identification results
obtained by sequencing and the data were categorized as
follows: (1) correct identification at the species level;
(2) correct identification at the genus level, including differ-
ent species within the Prevotella genus; (3) misidentification
(minor error: different Prevotella species; major error: differ-
ent genus); and (4) no identification.
16S rRNA gene sequencing
A “gold standard” 16S rRNA gene sequencing of all isolates
was carried out in the central laboratory in Turkey using the
methodology described by Song et al. [12]. Sequences were
analyzed using GenBank (www.ncbi.nlm.nih.gov). Identifica-
tion at species level was accepted in the presence of ≥99.0%
similarity with the 16S rRNA gene sequence and 97.0%–99.0%
similarity at the genus level [13].
RESULTS
All 314 Prevotella isolates were identified at the species level
with ≥99.0% sequence similarity using the 16S RNA gene
sequencing. A total of 19 different Prevotella species were
identified, most of which were P. bivia (n= 74), followed by
P. buccae (n= 41). P. nigrescens and P. denticola were
represented equally (34 isolates each), but some of the species
were present only in very low numbers (≤4 isolates), such as
P. buccalis, P. conceptionensis, P. corporis, P. histicola,
P. salivae, and P. veroralis. Table II shows the distribution
of the Prevotella spp. identified by the 16S RNA gene
sequencing and the identification results obtained by the
MALDI Biotyper at the isolation sites applying different
databases (Table I) and by the VITEK MS in the central
laboratory. Concordant species-level identification between
the three identification systems was measured; 16S rRNA
gene sequencing, MALDI Biotyper, and VITEK MS gave
the same species-level identification in 76.4% (n= 240)
of the isolates (Table II). There were discrepancies (minor
or major errors) compared with the sequencing data for the
remaining 74 (23.6%) isolates. Discrepant results are shown
in Table III.
Comparing the sequencing data with the identification
obtained by the MALDI Biotyper using different databases at
the collecting sites, 281 (89.4%) of the 314 isolates were
identified correctly at the species level and 33 isolates were
only correctly identified at genus level showing different
species (minor error) or only being identified as Prevotella
spp. (Table III). Most of the misidentified organisms
belonged to P. bivia, P. buccae, P. denticola, and P. timo-
nensis, but many other species were misidentified by showing
Table I. Number of Prevotella strains collected in different countries and the MALDI Biotyper software and database used for their
identification at the different collection sites
Collecting sites
(no. of isolates)
No. of strains
identified on
species/genus level
by Biotypera
No. of different
Prevotella spp.
identified by Biotyper
at the collection sites
Data about the Biotyper used
Software Database
No. of Prevotella
spp./MSPs in the
database
Belgium (45) 41/4 14 3.0 5,989 31/77b
Croatia (33) 33/0 6 3.1 5,989 31/77
Denmark (29) 28/1 9 3.1 6,903 31/126
France (45) 40/5 12 3.0 5,627 23/53
Great Britain (41) 41/0 8 3.0 5,989 31/77
Hungary (47) 46/1 9 3.0 5,627 23/53
The Netherlands (45) 45/0 12 3.0 4,613 23/52
Slovenia (29) 29/0 12 3.0 5,627 23/53
Note: MALDI: matrix-assisted laser desorption ionization; MSPs: main spectra profiles.
aSpecies-level identification was accepted if log score was ≥2.000 and genus-level identification was accepted if log score was ≥1.700–<2.000.
bIn this center, an extended database was used according to Wybo et al. [9].
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other species as well. The MALDI Biotyper database versions
DB 4613 and DB 5627 did not contain P. conceptionensis, P.
timonensis, or P. veroralis; therefore, six isolates evaluated by
these data sets were only identified at the genus level by the
MALDI Biotyper (Table III).
Comparative analysis of the identification obtained by the
VITEK MS system and the 16S RNA gene sequencing of the
isolates revealed that VITEK MS correctly identified 253
isolates (80.6%) at the species level and 276 (87.9%) at the
genus level (Table II) and misidentified 27 isolates with
minor error (n= 23) or major error (n= 4; Table III). A
total of 34 isolates (10.8%) were not identified. Thirty-three
isolates from five Prevotella species (P. bergensis, P.
conceptionensis, P. corporis, P. histicola, and P. nanciensis)
were not available in the VITEK MS IVD 3.0 database, and
were not identified or misidentified as different Prevotella
species or different genus (Tables II and III).
DISCUSSION
Recently, in microbiological diagnostic laboratories, there is
an increased usage of the MALDI-TOF MS technique for
rapid identification of clinically significant bacteria
including anaerobes [8]. Various studies indicated that the
performance of the MALDI-TOF MS systems is highly
Table II. The distribution of Prevotella species according to the sequencing data and identification results obtained by MALDI Biotyper and
VITEK MS
16S rRNA gene sequencing
MALDI Biotyper used at the
collecting sites VITEK MS used at the central laboratory
Concordant
species
identification by
the two MS
systems (n)Prevotella species n (%)
Correct species ID
(n)
Correct genus ID
(n)
Correct species ID
(n)
Correct genus ID
(n)
P. baroniae 13 (4.1) 12 13 11 12 11
P. bergensisa 12 (3.8) 10 12 0 1 0
P. bivia 74 (23.6) 69 74 74 74 69
P. buccae 41 (13.1) 36 41 38 38 36
P. buccalis 4 (1.3) 3 4 4 4 3
P. conceptionensisa,b 1 (0.3) 0 1 0 0 0
P. corporisa 4 (1.3) 3 4 0 1 0
P. denticola 34 (10.8) 30 34 32 34 30
P. disiens 18 (5.7) 17 18 17 17 17
P. histicolaa 4 (1.3) 3 4 0 4 0
P. intermedia 9 (2.9) 9 9 7 8 7
P. melaninogenica 27 (8.6) 25 27 25 26 25
P. nanceiensisa 12 (3.8) 12 12 0 2 0
P. nigrescens 34 (10.8) 33 34 24 29 24
P. oralis 5 (1.6) 3 5 5 5 3
P. oris 8 (2.5) 8 8 8 8 8
P. salivae 4 (1.3) 3 4 2 4 2
P. timonensis 8 (2.5) 4 8 4 7 4
P. veroralis 2 (0.6) 1 2 2 2 1
Total [n (%)] 314 (100) 281 (89.4) 314 (100) 253 (80.6) 276 (87.9) 240 (76.4)
Note: Concordant species identification by the two MALDI-TOF MS systems is also included. MALDI: matrix-assisted laser desorption ionization;
MS: mass spectrometry.
aNot included in the database of the VITEK MS system during the investigation.
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dependent on the expansion of the accompanying databases
and the specific group of isolates studied [4–7, 14]. Recent
reports show that the MALDI-TOF MS can provide identi-
fication for >90% of anaerobes [5, 10], whereas initial studies
put this number at <70% [7, 15]. The inclusion of sequenced
clinical isolates to the databases of the MALDI-TOF systems
has also been suggested [9, 16].
To support this trend, in this multicenter study, we
compared the applicability of two MALDI-TOF MS systems
for the identification of Prevotella species and compared the
results with 16S rRNA gene sequencing data. The results
showed that the performances of VITEK MS and MALDI
Biotyper were highly accurate for species identification
(80.6% and 89.4%, respectively) and were even better for
genus-level identification (87.9% and 100%, respectively).
However, 33 isolates from five different Prevotella species,
such as P. bergensis, P. conceptionensis, P. corporis,
P. histicola, and P. nanciensis, were not identified or
misidentified by the current VITEK MS database version
3.0, which does not cover these Prevotella species. Out of the
different databases used for the MALDI Biotyper during
this study, some species of Prevotella (P. concepcionensis,
P. veroralis, and P. timonensis) were also unavailable,
which also influenced the identification accuracy of the
system.
Previous studies on the identification of anaerobic bacte-
ria with MALDI-TOF MS used only a few Prevotella isolates
representing limited number of species [5, 15, 17–20]. All
those earlier studies that focused for the identification of
Prevotella species used the MALDI Biotyper in comparison
with 16S rRNA gene sequencing. The first of these studies
was published by Wybo et al. [9] and was conducted in 2012.
This study tested 102 clinical isolates belonging to different
species of Prevotella of which only 62.7% were identified at
the species level and 73.5% at the genus level. Accurate
species and genus identification went up to 83.3% and
89.2%, respectively, when the commercial database was
extended with in-house reference spectra from 23 sequenced
Prevotella reference strains and 7 clinical isolates. The second
study, Gursoy et al. [10] in 2017, used 123 oral Prevotella
isolates to test the diagnostic accuracy of the MALDI Bio-
typer. This study yielded 88.6% accuracy at the species level
and 100% accuracy at the genus level. The most likely reason
for this increase in accuracy in the past 5 years is the
expanded database of the MALDI Biotyper covering more
Prevotella spp. The database used by Wybo et al. [9] con-
tained 20 Prevotella species, whereas the database for the
2017 study by Gursoy et al. [10] contained 30. The results of
this study (89.2% of species-level identification of 314 iso-
lates), obtained using MALDI Biotyper system with different
main spectra profiles of 23–31 Prevotella spp. in the databases
used in the collecting laboratories, are similar to those ones
obtained by Gursoy et al. [10].
The first study evaluating how well the VITEK MS
(database version 2.0) identifies anaerobic bacteria on a
multicenter level was conducted by Garner et al. [21]. This
study tested a total of 652 anaerobic clinical isolates, includ-
ing 90 isolates from five different Prevotella species (P. bivia,
P. buccae, P. denticola, P. intermedia, and P. melaninogenica).
Of these strains, 91.1% were identified at the species level. In
this study, using the VITEK MS database version 3.0, 95.1%
of the Prevotella strains belonging to the same species were
correctly identified at the species level. The overall lower
percentage of the species-level identification by the VITEK
MS achieved in this study evaluating all the isolates may be
due to the much higher number of species represented. The
strains used in this study belonged to 19 different species,
including species not present in the current VITEK MS
database.
There are limited number of studies, which compare the
performance of the two commercially available MALDI-TOF
MS systems especially for the identification of special anaer-
obic bacteria such as Prevotella. The limitation of conducting
this type of research is the relatively low number of Prevotella
species in the VITEK MS database (16 species at the mo-
ment), compared with the MALDI Biotyper databases, which
contained reference spectra for 23 species (DB 4613 and DB
5627) and 31 species (DB 5989 and DB 6903) used in this
study. However, this study also shows that, besides the
number of the species present in the databases, many other
factors such as incubation time, sample preparation, or
maintenance of the system (which were not tested during
this study) may influence the correct species-level identifica-
tion as well [22].
The strengths of this study are the wide range of clinically
relevant Prevotella spp. tested and the use of 16S rRNA gene
sequencing as the reference method. However, there were
some limitations of this study such as the identification of the
isolates by the two MALDI-TOF MS systems was not carried
out in the same laboratory from the same culture plate
simultaneously. Furthermore, the collecting sites used differ-
ent MALDI Biotyper databases for the original identification
of the isolates and we have not collected data whether the
sample preparation was the same in all sites where the
MALDI Biotyper was used. Several database developments
for both systems were carried out, since we closed down this
study [16].
In conclusion, both MALDI-TOF MS systems performed
well in identifying most clinically important Prevotella
strains. MALDI-TOF MS is a reliable alternative to 16S
rRNA gene sequencing for these species, considered to be
the gold standard for identification of bacteria. Moreover, it is
easier and more applicable in routine laboratories. However,
expanding and optimizing the MS databases to include
reference spectra for more species is needed. Controlled
sample preparation and careful evaluation of the cut-off
values to accept species determination are advisable. Accu-
rate and simple identification of isolates will increase interest
in studying anaerobic organisms, enhancing our knowledge
of the epidemiology, pathogenicity, and clinical relevance of
Prevotella species.
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